Login
$DBMM
$0.00 +$0.00 (0.0%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of May 31, 2026
Q2 FY2026
As of Feb 28, 2026
Q1 FY2026
As of Nov 30, 2025
Q4 FY2025
As of Aug 31, 2025
Q3 FY2025
As of May 31, 2025
Q2 FY2025
As of Feb 28, 2025
Q1 FY2025
As of Nov 30, 2024
Q4 FY2024
As of Aug 31, 2024
Q3 FY2024
As of May 31, 2024
Q2 FY2024
As of Feb 29, 2024
Q1 FY2024
As of Nov 30, 2023
Q4 FY2023
As of Aug 31, 2023
Q3 FY2023
As of May 31, 2023
Q2 FY2023
As of Feb 28, 2023
Q1 FY2023
As of Nov 30, 2022
Q4 FY2022
As of Aug 31, 2022
Q3 FY2022
As of May 31, 2022
Q2 FY2022
As of Feb 28, 2022
Q1 FY2022
As of Nov 30, 2021
Q4 FY2021
As of Aug 31, 2021
CURRENT ASSETS
Cash
Accounts receivable, net
Prepaid expenses and other current assets
Total current assets
Property and equipment - net
Total assets
CURRENT LIABILITIES
Accounts payable and accrued expenses
Accrued interest
Accrued compensation
Derivative liability
Loans payable
Officers loans payable
Convertible debentures
Liabilities current
Loan payable, net of short-term portion
TOTAL LIABILITIES
STOCKHOLDERS’ DEFICIT
Preferred stock, Series
Preferred Stock, Series 1
Preferred Stock ,Series 2
Common stock, par value .001; authorized 2,000,000,000 shares; 865,218,631 shares issued and outstanding
Additional paid in capital
Other comprehensive loss
Accumulated deficit
TOTAL STOCKHOLDERS’ DEFICIT
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support